RNU6-731P

Across TCGA pan-cancer cohorts, RNU6-731P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RNU6-731P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RNU6-731P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6-731P is over-expressed in tumor.

KIRC, STAD, and LIHC are the cancer types where RNU6-731P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-731P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.064	.033	3	view →
STAD	All	All	+0.551	.038	1	view →
LIHC	All	All	+0.057	.031	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RNU6-731P–KIRC

Open the KIRC breakdown →